PTPN1 and Hyperglycemia: The effects of apigenin against hyperglycemia and IR can be exerted through mechanisms including inhibition of PTP1B expression, maintaining the activity of anti-oxidant enzymes, reducing the intracellular ROS production, cellular DNA damage and protein carbonylation, and attenuating β cell apoptosis and dysfunction through regulating the mitochondrial membrane potential.